There are 2789 resources available
1478P - Trends in treatment patterns among Medicare fee-for-service (FFS) patients receiving treatment for metastatic pancreatic cancer
Presenter: Gabriela Dieguez
Session: ePoster Display
1537P - Dissecting inflammation in patients with desmoid fibromatosis to identify prognostic biomarkers
Presenter: Viviana Vallacchi
Session: ePoster Display
1538P - Germline testing of sarcoma revealed frequent mutations in genes involved in DNA repair, RNA metabolism, and epigenetic regulation
Presenter: Haicheng Gao
Session: ePoster Display
1638P - Experience with telemedicine during COVID-19 pandemic
Presenter: Sandra Soriano
Session: ePoster Display
1639P - Impact of COVID-19 on ongoing oncological and hematological treatment strategy
Presenter: Arnaud Bayle
Session: ePoster Display
1640P - Impact of COVID-19 vaccination campaign on psychological status in cancer patients (pts)
Presenter: Daniela Tregnago
Session: ePoster Display
1641P - Patient preferences towards the application of telemedicine on cancer care during Coronavirus disease 2019 (COVID-19) pandemic. ONCOTELEMED STUDY
Presenter: Paula Ribera
Session: ePoster Display
1485P - Identification of novel protein biomarkers for FOLFIRINOX-based chemotherapy response in advanced pancreatic adenocarcinoma using patient omics and Bayesian AI
Presenter: A. Moser
Session: ePoster Display
1486P - Clinicopathological characteristics and prognostic factors of ampullary cancer: A tertiary care centre experience over 10 years
Presenter: Aditya Singla
Session: ePoster Display
1487TiP - A randomized non-comparative phase II study of maintenance therapy with FOLFIRI alone or in combination with Tedopi vaccine after induction therapy with FOLFIRINOX in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (TEDOPAM – D17-01 PRODIGE 63 STUDY)
Presenter: Marc Hilmi
Session: ePoster Display